It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Kidney tumours are among the most common solid tumours in children, comprising distinct subtypes differing in many aspects, including cell-of-origin, genetics, and pathology. Pre-clinical cell models capturing the disease heterogeneity are currently lacking. Here, we describe the first paediatric cancer organoid biobank. It contains tumour and matching normal kidney organoids from over 50 children with different subtypes of kidney cancer, including Wilms tumours, malignant rhabdoid tumours, renal cell carcinomas, and congenital mesoblastic nephromas. Paediatric kidney tumour organoids retain key properties of native tumours, useful for revealing patient-specific drug sensitivities. Using single cell RNA-sequencing and high resolution 3D imaging, we further demonstrate that organoid cultures derived from Wilms tumours consist of multiple different cell types, including epithelial, stromal and blastemal-like cells. Our organoid biobank captures the heterogeneity of paediatric kidney tumours, providing a representative collection of well-characterised models for basic cancer research, drug-screening and personalised medicine.
Pre-clinical cell culture models capturing the heterogeneity of childhood kidney tumours are limited. Here, the authors establish and characterise an organoid biobank of tumour and matched normal organoid cultures from over 50 children with different subtypes of kidney cancer.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 Oncode Institute, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (GRID:grid.499559.d)
2 Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, The Netherlands (GRID:grid.419927.0) (ISNI:0000 0000 9471 3191); University Medical Center, Department of Nephrology and Hypertension, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
3 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (GRID:grid.487647.e)
4 Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, The Netherlands (GRID:grid.419927.0) (ISNI:0000 0000 9471 3191)
5 University Medical Center, Department of Nephrology and Hypertension, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
6 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (GRID:grid.487647.e); University Medical Center, Department of Pathology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
7 University College London, UCL Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
8 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (GRID:grid.487647.e); Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany (GRID:grid.487647.e); Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)
9 Oncode Institute, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (GRID:grid.499559.d); Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, The Netherlands (GRID:grid.419927.0) (ISNI:0000 0000 9471 3191)